Literature DB >> 16752081

Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment: a cohort study.

Stéphane Vignes1, Raphaël Porcher, Annick Champagne, Alain Dupuy.   

Abstract

BACKGROUND: Lymphedema is a frequent complication after breast cancer treatment. Reduction of lymphedema volume is obtained during an intensive phase with daily physiotherapy. Response to treatment remains unknown prior treatment. We purposed to analyze predictors of response of lymphedema treatment throughout the first course of physiotherapy.
DESIGN: Patients with secondary arm lymphedema were recruited in a single lymphology unit between 2001 and 2004. For each patient, the following data were recorded: characteristics of breast cancer treatment, patient characteristics, body mass index and lymphedema volume prior and at the end of treatment.
RESULTS: Three hundred and fifty-seven women (mean age: 53+/-11 years) were included. Initial excess volume of lymphedema was correlated to body mass index and duration of lymphedema. Mean duration of intensive decongestive therapy was 11.8+/-3.3 days. Mean excess volume of lymphedema was 1067+/-622 ml prior treatment and 663+/-366 ml after treatment (p<0.001), percentage of excess volume of lymphedema was 59+/-34% and 36+/-19%, respectively. Absolute volume reduction was 404+/-33 ml (p<0.001). Body mass index and duration of lymphedema before treatment were the two predictors of absolute reduction of lymphedema volume. Higher was the body mass index or the duration of lymphedema, more important was the absolute reduction of lymphedema volume. Mean relative percentage of volume reduction was 36+/-14% whatever mass index or the duration of lymphedema was.
CONCLUSION: Duration of lymphedema from cancer treatment and body mass index were the only two predictors of absolute reduction of lymphedema volume after intensive decongestive physiotherapy. For all patients this latter treatment is highly effective in management of secondary upper limb lymphedema after breast cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16752081     DOI: 10.1007/s10549-005-9021-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

1.  Factors influencing response to lymphedema treatment in patients with breast cancer-related lymphedema.

Authors:  Sibel Eyigör; Ece Cinar; Ismail Caramat; Burcu Koc Unlu
Journal:  Support Care Cancer       Date:  2015-02-08       Impact factor: 3.603

2.  Quantitative and morphologic change associated with breast cancer-related lymphedema. Comparison of 3.0T MRI to external measures.

Authors:  Gregory C Gardner; Joshua P Nickerson; Richard Watts; Lee Nelson; Kim L Dittus; Patricia J O'Brien
Journal:  Lymphat Res Biol       Date:  2014-03-21       Impact factor: 2.589

3.  Ultrasonographic findings and the clinical results of treatment for lymphedema.

Authors:  Kiyoaki Niimi; Masafumi Hirai; Hirohide Iwata; Keiko Miyazaki
Journal:  Ann Vasc Dis       Date:  2014-12-25

4.  Use of Dual-Energy X-Ray Absorptiometry to Assess Soft Tissue Composition in Breast Cancer Survivors With and Without Lymphedema.

Authors:  Betty J Smoot; Judy Mastick; John Shepherd; Steven M Paul; Kord M Kober; Bruce A Cooper; Yvette P Conley; Niharika Dixit; Marilyn J Hammer; Mei R Fu; Gary Abrams; Christine Miaskowski
Journal:  Lymphat Res Biol       Date:  2021-11-18       Impact factor: 2.349

5.  The results of the intensive phase of complete decongestive therapy and the determination of predictive factors for response to treatment in patients with breast cancer related-lymphedema.

Authors:  Dilek Keskin; Meltem Dalyan; Sibel Ünsal-Delialioğlu; Ülkü Düzlü-Öztürk
Journal:  Cancer Rep (Hoboken)       Date:  2020-01-03

Review 6.  Nonoperative Treatment of Lymphedema.

Authors:  Mark V Schaverien; Julie A Moeller; Sarah D Cleveland
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

7.  The effects of complex decongestive therapy on kinesthetic sense of hands, upper extremity function, and quality of life in patients with breast cancer-related lymphedema.

Authors:  Hilal Yeşil; Sibel Eyigör; Menekşe İnbat; Ferah Bulut
Journal:  Turk J Phys Med Rehabil       Date:  2021-05-25

8.  Long-term effects of complex decongestive therapy in breast cancer patients with arm lymphedema after axillary dissection.

Authors:  Jung Min Hwang; Ji Hye Hwang; Tae Won Kim; Seung Yeol Lee; Hyun Ju Chang; In Ho Chu
Journal:  Ann Rehabil Med       Date:  2013-10-29

9.  Clinical effectiveness of decongestive treatments on excess arm volume and patient-centered outcomes in women with early breast cancer-related arm lymphedema: a systematic review.

Authors:  Eunice Jeffs; Emma Ream; Cath Taylor; Debra Bick
Journal:  JBI Database System Rev Implement Rep       Date:  2018-02

10.  Building a Multidisciplinary Comprehensive Academic Lymphedema Program.

Authors:  Mark V Schaverien; Donald P Baumann; Jesse C Selber; Edward I Chang; Matthew M Hanasono; Carrie Chu; Summer E Hanson; Charles E Butler
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-03-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.